These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 23667609
1. Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer. Ji L, Li H, Gao P, Shang G, Zhang DD, Zhang N, Jiang T. PLoS One; 2013; 8(5):e63404. PubMed ID: 23667609 [Abstract] [Full Text] [Related]
8. Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman's rank correlation analysis. Cai B, Miao Y, Liu Y, Xu X, Guan S, Wu J, Liu Y. PLoS One; 2013; 8(8):e69611. PubMed ID: 24013781 [Abstract] [Full Text] [Related]
9. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell. Wang Z, Sun X, Feng Y, Wang Y, Zhang L, Wang Y, Fang Z, Azami NLB, Sun M, Li Q. Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143 [Abstract] [Full Text] [Related]
10. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. Song NY, Kim DH, Kim EH, Na HK, Surh YJ. Ann N Y Acad Sci; 2009 Aug; 1171():210-6. PubMed ID: 19723058 [Abstract] [Full Text] [Related]
11. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR, Jia XH, Wang H, Yi YJ, Wang JY, Li YJ. Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [Abstract] [Full Text] [Related]
12. RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells. Shao SL, Cui TT, Zhao W, Zhang WW, Xie ZL, Wang CH, Jia HS, Liu Q. Asian Pac J Cancer Prev; 2014 May; 15(24):10597-601. PubMed ID: 25605145 [Abstract] [Full Text] [Related]
13. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Singh A, Wu H, Zhang P, Happel C, Ma J, Biswal S. Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644 [Abstract] [Full Text] [Related]
14. Fasting induces nuclear factor E2-related factor 2 and ATP-binding Cassette transporters via protein kinase A and Sirtuin-1 in mouse and human. Kulkarni SR, Donepudi AC, Xu J, Wei W, Cheng QC, Driscoll MV, Johnson DA, Johnson JA, Li X, Slitt AL. Antioxid Redox Signal; 2014 Jan 01; 20(1):15-30. PubMed ID: 23725046 [Abstract] [Full Text] [Related]
15. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer and its clinical significance]. Yang L, Hu H, Deng Y, Bai Y. Zhongguo Fei Ai Za Zhi; 2014 Nov 01; 17(11):769-77. PubMed ID: 25404266 [Abstract] [Full Text] [Related]
16. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y. Eur J Cancer; 2010 Jun 01; 46(9):1692-702. PubMed ID: 20371173 [Abstract] [Full Text] [Related]
18. miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1. Liu H, Wu X, Huang J, Peng J, Guo L. Int J Exp Pathol; 2015 Aug 01; 96(4):240-7. PubMed ID: 26108539 [Abstract] [Full Text] [Related]
19. Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Kang HK, Lee E, Pyo H, Lim SJ. Mol Cancer Ther; 2005 Sep 01; 4(9):1358-63. PubMed ID: 16170027 [Abstract] [Full Text] [Related]
20. Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival. Ji L, Wei Y, Jiang T, Wang S. Int J Clin Exp Pathol; 2014 Sep 01; 7(3):1124-31. PubMed ID: 24695690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]